Enjoy this webinar: 

FROM CONTACT TO CREDIBILITY:
A CONVERSATION ABOUT TRUSTED AUTONOMOUS AND INTELLIGENT SYSTEMS CERTIFICATION FOR COVID AND BEYOND

Recorded: 14 October 2020
AVAILABLE NOW ON-DEMAND


The desire to halt the spread of COVID-19 and the good intentions of multiple governments and technologists by creating Contact Tracing Apps and technologies is laudable.  But where any methodologies or applications along these lines are framed in existing data access schemes that prevent genuine disclosure or transparency on human rights, the ultimate purpose of increasing human wellbeing in its broadest, long term, and holistic sense will not be achieved. 

As a demonstrated commitment to  “Raise the World’s Standards,” the IEEE ECPAIS Community has focused on achieving increased due diligence around areas of accountability, transparency, and avoiding algorithmic bias.  For over two years, multiple global experts have created detailed conformance criteria allowing companies or end users to rigorously test their Autonomous and  Intelligent Systems-oriented products against the criteria.  Now the ECPAIS Community has created a new framework built on its  existing criteria oriented specifically around CTA/CTT application.  And we need your insights to help best understand how these criteria can be released to the world in the most impactful, safe, and transformative way possible. 

As part of our upcoming webinar, “From Contact to Credibility” you will hear from experts on multiple issues related to COVID technologies, Autonomous and  Intelligent Systems Certification, and CTA/CTT issues at large.  

Registrants will learn about recommendations submitted for consideration on the IEEE Certification Criteria - Addressing Challenges in Ethical Transparency, Accountability, and Privacy of CTA/CTT use case.  The webinar will have an open forum, including speakers, panels, and round table discussion formats on significant industry issues to include:

  • A lack of or undermined public trust that impedes the effectiveness of the implementations. 
  • Threats to privacy.
  • Lack of evidence for the need for digital contact tracing to support manual contact tracing. Fear of loss of confidentiality and the subsequent stigma, discrimination, or abuse of individuals or population who are not currently protected.
  • Voluntary uptake and continued consent.
  • Digital exclusion of people without smartphone access. Understanding wide and consistent use among a large proportion of the population is needed for meaningful results.
  • Interoperation challenges across borders and state boundaries.

Your participation can help drive the future direction for ethical transparency, accountability, and avoiding algorithmic bias.

Download the ECPAIS CTA/CTT use case 

Learn more about the Ethics Certification Program for Autonomous and Intelligent Systems (ECPAIS) 

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company

NAME

Title, Company